Evidence map›Paper›PMID 40718386›Full record

ArticleFrontiers in human neuroscience2025

Cerebral/Cortical visual impairment (CVI) in Down syndrome: a case series.

Elizabeth Boatwright, Rudaina Banihani, Ilse Willems, Kathleen Lehman, Ellen Mazel, Hannah Mark, Mike Wong, Silvia Vietzman, Arvind Chandna, Gena Heidary and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elizabeth BoatwrightIndependent Internal Medicine-Pediatrics Physician, Educator, and Researcher, Colorado Springs, CO, United States.
Rudaina BanihaniDAN Women & Babies Program, Department of Newborn & Developmental Pediatrics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Ilse WillemsCVI Center, Perkins School for the Blind, Educational Programs, Watertown, MA, United States.
Kathleen LehmanInstitute on Human Development and Disability, University of Washington, Seattle, WA, United States.
Ellen MazelCVI Center, Perkins School for the Blind, Educational Programs, Watertown, MA, United States.
Hannah MarkDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, United States.
Mike WongSeeLab, Smith-Kettlewell Eye Research Institute, San Francisco, CA, United States.
Silvia VietzmanSeeLab, Smith-Kettlewell Eye Research Institute, San Francisco, CA, United States.
Arvind ChandnaSeeLab, Smith-Kettlewell Eye Research Institute, San Francisco, CA, United States.
Gena HeidaryDepartment of Ophthalmology, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States.
DSMIG DS+CVI Workgroup

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral/Cortical visual impairment (CVI), a brain-based visual condition, is a leading cause of childhood blindness and low vision but remains underdiagnosed in individuals with Down syndrome (DS). This report presents three case studies of adolescents with DS and CVI (DS + CVI), illustrating how CVI can manifest alongside the developmental, cognitive, behavioral, and social profiles of individuals with DS. We describe comprehensive ophthalmological evaluations, assessment for visual perceptual deficits with a screener questionnaire, functional vision assessments, and neuroimaging (when available). Through a detailed retrospective examination of these cases, we explore the complex interplay between CVI and DS, emphasizing how CVI-related challenges-such as difficulties with visual attention, spatial perception, processing, and navigation-are often misattributed to DS alone or to other more commonly recognized co-occurring conditions in DS. Diagnostic overshadowing, coupled with a lack of standardized screening tools, has led to delayed diagnoses and missed opportunities for intervention. Our findings highlight the importance of recognizing CVI in individuals with DS using reliable tools for assessment of functional vision to better appreciate the effect on their diverse developmental outcomes, and to incorporate CVI into our understanding of the DS phenotype. These case reports underscore the need for further research to determine the prevalence and impact of CVI in DS and advocate for the development of tailored screening protocols and evidence-based interventions to support individuals with DS + CVI across the lifespan.

Indexed as

case reportCerebral/Cortical visual impairment (CVI)Down syndrome and Cerebral/Cortical visual impairment (DS + CVI)Down syndrome (DS)/Trisomy 21functional vision assessment (FVA)Top-11 Higher Visual Function Question Inventory (HVFQI)visual attentionvisual perception

Identifiers

PMID40718386
PMCPMC12291067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.